EQUITY (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended				12 Months Ended
	Feb. 22, 2022	Nov. 30, 2022	Oct. 31, 2022	Mar. 31, 2022	Apr. 30, 2018	Dec. 31, 2022	Dec. 31, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued during period					107,985
Proceeds from Issuance of Common Stock							$ 25,000
Commission rate							3.00%
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued during period						724,999
Stock issued shares acquistions						29,940
Securities Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, shares				4,933,333
Sale of stock, price per share				$ 3.00
Purchase of warrants				1,000,000
Exercise price of warrants				$ 4.50
Warrant exercisable description				The warrants are not exercisable until after six months and expire three years from the date of issuance
Proceeds from private placemenrt				$ 2,175
Securities Purchase Agreement [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued during period				724,999
Securities Purchase Agreement [Member] | Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Purchase of warrants				146,959
Securities Purchase Agreement [Member] | Investor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from private placemenrt				$ 12,625
Joint Venture Agreement [Member] | Mida Biotech BV [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued shares acquistions	29,940					29,940
Amendment Consent And Waiver Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, shares		215,502	215,502
Exercise price of warrants		$ 2.50	$ 2.50